News

Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a ...
The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...
Being hailed as the next holy grail skincare ingredient; exosomes are a regenerative ingredient that act as messengers ...
The Gwyneth Paltrow-approved choice for cellular health - To combat stress and toxin exposure, phospholipids have been ...
Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...
BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the ...
Alabama shoppers may soon see hemp-derived THC-infused seltzer brand Herbal Oasis on shelves near them, unless a proposed law to regulate the sale of consumable hemp products prevents the company’s ...
From cutting-edge sleep specialists to stylish fitness gear, these are the new wellness brands worth having on your ...
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (U.S. FDA) has approved Jobevnetm (bevacizumab-nwgd), ...
Pacira settles Exparel patent cases, grants Fresenius phased license for generic sales beginning in 2030, with full access no ...
The trial is designed to assess LP-310’s tolerability, preliminary efficacy, and safety in adults with symptomatic OLP.